Novo Slides 14% On Early Q4 Results Forecasting 2026 Sales Drop
04 Feb 2026 //
BIOSPACE
FDA Rejects Az`s Subcutaneous Version Of Lupus Drug Saphnelo
04 Feb 2026 //
FIERCE PHARMA
NMD Accelerates Rare Disease Asset Despite primary endpoint miss
04 Feb 2026 //
FIERCE BIOTECH
Pfizer Links Monthly GLP-1 To Competitive Weight Loss In Phase 2
04 Feb 2026 //
FIERCE BIOTECH
Biologics, biosimilars are the focus of India`s $1.1B investment
04 Feb 2026 //
FIERCE PHARMA
Abbvie Seeks FDA & EMA Approval For Upadacitinib
04 Feb 2026 //
PRESS RELEASE
Sanofi Initiates €1B Share Buyback Mandate
04 Feb 2026 //
PRESS RELEASE
Merck lines up $70B+ in revenue opportunities over next decade
04 Feb 2026 //
FIERCE PHARMA
Roche Continues RNA Return With $1.7B Deal For Sanegene Drug
03 Feb 2026 //
FIERCE BIOTECH
Drugs In Development
Market Intel

Market Place
Sourcing Support